117 related articles for article (PubMed ID: 26530757)
21. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.
Nguyen QN; Shiu AS; Rhines LD; Wang H; Allen PK; Wang XS; Chang EL
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1185-92. PubMed ID: 19632064
[TBL] [Abstract][Full Text] [Related]
22. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery.
Teh BS; Bloch C; Paulino AC; Shen S; Hinckley L; Baskin D; Butler EB; Amato R
Clin Genitourin Cancer; 2007 Jun; 5(5):334-7. PubMed ID: 17645831
[TBL] [Abstract][Full Text] [Related]
23. Lobulated enhancement evaluation in the follow-up of liver metastases treated by stereotactic body radiation therapy.
Jarraya H; Borde P; Mirabel X; Ernst O; Boulanger T; Lartigau E; Ceugnart L; Kramar A; Taieb S
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):292-8. PubMed ID: 25968825
[TBL] [Abstract][Full Text] [Related]
24. Incidence and Time of Onset of Osseous Pseudoprogression in Patients With Metastatic Spine Disease From Renal Cell or Prostate Carcinoma After Treatment With Stereotactic Body Radiation Therapy.
Jabehdar Maralani P; Winger K; Symons S; Machnowska M; Heyn C; Helmi A; Chan A; Tseng CL; Sahgal A
Neurosurgery; 2019 Mar; 84(3):647-654. PubMed ID: 29618107
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiosurgery for spinal metastases with or without separation surgery.
Bate BG; Khan NR; Kimball BY; Gabrick K; Weaver J
J Neurosurg Spine; 2015 Apr; 22(4):409-15. PubMed ID: 25635638
[TBL] [Abstract][Full Text] [Related]
26. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.
Erler D; Brotherston D; Sahgal A; Cheung P; Loblaw A; Chu W; Soliman H; Chung H; Kiss A; Chow E; Poon I
Radiother Oncol; 2018 May; 127(2):304-309. PubMed ID: 29706460
[TBL] [Abstract][Full Text] [Related]
27. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.
Muacevic A; Kreth FW; Mack A; Tonn JC; Wowra B
Minim Invasive Neurosurg; 2004 Aug; 47(4):203-8. PubMed ID: 15346315
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
30. Patient survival after surgery for osseous metastases from renal cell carcinoma.
Lin PP; Mirza AN; Lewis VO; Cannon CP; Tu SM; Tannir NM; Yasko AW
J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of bone metastases from urological malignancies: an analysis of 70 cases.
Toğral G; Arıkan M; Aktaş E; Öztürk R; Güven O; Eksioğlu F
Acta Orthop Traumatol Turc; 2015; 49(6):634-40. PubMed ID: 26511690
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney.
Svedman C; Karlsson K; Rutkowska E; Sandström P; Blomgren H; Lax I; Wersäll P
Acta Oncol; 2008; 47(8):1578-83. PubMed ID: 18607859
[TBL] [Abstract][Full Text] [Related]
33. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy.
Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
AJR Am J Roentgenol; 2010 Jun; 194(6):1470-8. PubMed ID: 20489085
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases.
Marko NF; Angelov L; Toms SA; Suh JH; Chao ST; Vogelbaum MA; Barnett GH; Weil RJ
World Neurosurg; 2010 Mar; 73(3):186-93; discussion e29. PubMed ID: 20860956
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
37. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of bone metastases from renal cell carcinoma].
Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
[TBL] [Abstract][Full Text] [Related]
39. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
[TBL] [Abstract][Full Text] [Related]
40. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
